Blog from IFPMA ADG Greg Perry following his visit to Cabo Verde
Find out here an insight that Greg Perry gives around WHO Afro Global Health Forum 2019
Read More
Thought Leader Series in Vaccines
A mustread from experts talking about the value of vaccines
Read More
Our response to Zika virus
Check here about the R&D blueprint against Zika
Read More
Women’s Cancer Initiative in the Americas
Partnership to improve prevention of women’s cancers and quality of cancer registries in LAC reaches 1 year milestone
Read More
Latest News
2019-01-10 07:49:44
R&D biopharmaceutical industry embraces NEW Code of Practice to boost business integrity worldwide
The new Code of Practice in place from 1 January 2019, imposes a complete ban on gifts and promotional aids ...
Read More2018-12-10 13:14:17
Unjela Kaleem joins global pharma association as Director of Communications
Geneva, 10 December 2018 – IFPMA, the global research-based biopharmaceutical industry association, is pleased to ...
Read More2018-12-05 12:00:49
R&D biopharmaceutical industry revamp ethical code to apply as base line of industry behavior worldwide
New R&D biopharmaceutical industry Code of Practice comes into effect on 1 January 2019. Changes ...
Read More2018-12-04 17:17:22
David A. Ricks Elected New President of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
David A. Ricks, Chairman and Chief Executive Officer, Eli Lilly and Company, takes over as ...
Read More2018-11-16 06:30:08
Pharma industry launches call for coalition of countries to pilot new incentives for antibiotic R&D
16 November, Geneva – The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) draws attention ...
Read More2018-11-13 09:35:59
The largest private sector coalition to provide sustainable solutions to curb antimicrobial resistance (AMR) has made strides in 2018 and calls for a coordinated and multi-pronged response from all stakeholders
The AMR Industry Alliance has made major strides in 2018 taking action across four different ...
Read More2018-10-29 10:25:29
The R&D biopharmaceutical industry supports the Astana Declaration and renewed political commitment towards the importance of primary health care
26 October 2018, Astana – The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the ...
Read More
Latest Statement
2019-09-09 13:06:56
New report provides a policy framework to support countries in implementing an effective life-course approach to immunization
GENEVA, 12 September 2019 – The report “Implementing a Life-Course Approach to Immunization” provides a policy framework for countries to ...
Read More2019-09-09 13:02:49
Industry and Stakeholders reaffirm their commitment to ensuring ethics and integrity across health systems
26 October 2018, Astana – The International Federation of Pharmaceutical ...
Read More2019-08-30 09:49:37
IFPMA calls for regulatory convergence to speed up development of much needed vaccines
26 October 2018, Astana – The International Federation of Pharmaceutical ...
Read More2019-08-22 16:13:46
IFPMA Statement on WHO Afro 69 agenda item 12 Framework for provision of essential health services through strengthened district/local health systems to support UHC in the context of the SDGs
26 October 2018, Astana – The International Federation of Pharmaceutical ...
Read More2019-05-27 16:21:25
IFPMA Statement at WHA72 agenda item 11.7 Access to medicines and vaccines
26 October 2018, Astana – The International Federation of Pharmaceutical ...
Read More2019-05-25 16:45:55
IFPMA Statement at WHA72 agenda item 12.10 The public health implications of implementation of the Nagoya Protocol
26 October 2018, Astana – The International Federation of Pharmaceutical ...
Read More2019-05-24 18:16:31
IFPMA Statement at WHA72 12.1 agenda item Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits
26 October 2018, Astana – The International Federation of Pharmaceutical ...
Read More
mailto:s.kaenzig@ifpma.org +41 22 338 32 49
direct line
Twitter skaenzig
Sadia Kaenzig - Communications Manager
Sadia manages communications on issues including regulatory, intellectual property protection, trade and the economic footprint of the research-based pharmaceutical industry, research and development ecosystem and innovation, vaccines including influenza vaccines, and biotherapeutics.
mailto:m.depol@ifpma.org +41 22 338 32 20
direct line
Twitter @MorganePol
Morgane De Pol - Communications and Public Affairs
Morgane manages communications on issues including the research-based pharmaceutical industry’s commitment to achieving sustainable and inclusive development, advancing Universal Health Coverage, designing transformational partnerships to build healthier societies, boosting innovation for neglected tropical diseases, expanding access to high quality treatments for infectious and chronic diseases, fighting counterfeit medicines, and promoting resilient and efficient health systems.
Our Brouchure
2015 Edition
A shared commitment to global health
At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.
Our Logo
Full colour EPS format
Our Logo
Full colour PNG format
FULL Name LOGO
Full colour EPS format
FULL Name LOGO
Full colour PNG format
Hot Topic
Pharmacovigilance: Do your bit, play your part!
Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is
Read MoreInterview
IFPMA 2015 interview series 'Biodiversity, human health, and pharma'
A must-watch: Dr Manisha A. Desai, assistant general patent counsel at Eli Lilly and Company, gives her take on the importance of the Convention of Biodiversity and the Nagoya Protocol for the pharma industry. What's key is to
Read MoreOur Blog
Five questions to .... Paola Barbarino
Paola Barbarino, Chief Executive Officer at Alzheimer's Disease International (ADI), talks to IFPMA about changing attitudes and perceptions surrounding dementia and Alzheimer's. Is mental health getting enough attention in the UHC discussions and what are your hopes for the upcoming UN High Level Meeting on UHC? Following on from the High-Level Meeting on Non-Communicable Diseases in 2018, we were both heartened and frustrated. Heartened by...
Read More
The search for a dementia cure rests on helping innovators
This article was originally published in the Financial Times on August 6, 2019. The search for a dementia cure rests on helping innovators Governments must steer private funding towards difficult diseases Innovation can change the maths of Alzheimer’s disease. But to do that, governments need to change the maths for innovators. The estimated annual global cost of care for people with Alzheimer’s and other forms...
Read More
Five questions to .... David Stewart
David Stewart, Associate Director, Nursing and Health Policy at the International Council of Nurses (ICN) talks to IFPMA about the importance of nurses in achieving universal health coverage. Earlier this year, Dr Tedros endorsed 2020 as the Year of Nurses and Midwives. What are your hopes for 2020? We have been working with Dr Tedros and other senior staff at WHO to raise the profile...
Read MoreLatest Tweets
